Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ezh2
|
ENSMUSG00000029687.10 | enhancer of zeste 2 polycomb repressive complex 2 subunit |
Atf2
|
ENSMUSG00000027104.12 | activating transcription factor 2 |
Ikzf1
|
ENSMUSG00000018654.11 | IKAROS family zinc finger 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_73892016_73892788 | Atf2 | 128 | 0.965209 | -0.13 | 3.3e-01 | Click! |
chr2_73892825_73893305 | Atf2 | 426 | 0.845460 | -0.12 | 3.9e-01 | Click! |
chr6_47594639_47594846 | Ezh2 | 288 | 0.901404 | 0.43 | 1.1e-03 | Click! |
chr6_47594140_47594637 | Ezh2 | 642 | 0.703720 | 0.29 | 3.3e-02 | Click! |
chr6_47595278_47595639 | Ezh2 | 117 | 0.963334 | -0.08 | 5.4e-01 | Click! |
chr6_47594929_47595230 | Ezh2 | 21 | 0.976356 | 0.05 | 7.2e-01 | Click! |
chr11_11657177_11657347 | Ikzf1 | 27741 | 0.134398 | -0.54 | 1.7e-05 | Click! |
chr11_11676160_11676311 | Ikzf1 | 8768 | 0.164607 | 0.50 | 1.1e-04 | Click! |
chr11_11690106_11690257 | Ikzf1 | 3736 | 0.192603 | -0.47 | 3.3e-04 | Click! |
chr11_11657539_11657728 | Ikzf1 | 27370 | 0.135061 | -0.46 | 3.6e-04 | Click! |
chr11_11689072_11689235 | Ikzf1 | 2708 | 0.222642 | -0.42 | 1.3e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr12_3236518_3237725 | 16.52 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr14_118230672_118230848 | 13.72 |
Gm4675 |
predicted gene 4675 |
5472 |
0.14 |
chr10_58227289_58228680 | 12.68 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr13_84346459_84346614 | 12.16 |
Gm26927 |
predicted gene, 26927 |
6423 |
0.24 |
chr11_88582890_88583759 | 11.19 |
Msi2 |
musashi RNA-binding protein 2 |
6823 |
0.27 |
chr15_103518626_103518966 | 10.84 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
3876 |
0.17 |
chr4_20777672_20778960 | 8.07 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr7_73222623_73222960 | 7.59 |
Gm30075 |
predicted gene, 30075 |
15740 |
0.16 |
chr16_63806861_63807216 | 7.58 |
Epha3 |
Eph receptor A3 |
56375 |
0.15 |
chr4_109762760_109763127 | 7.53 |
Gm12808 |
predicted gene 12808 |
8126 |
0.24 |
chr4_65839396_65839998 | 7.46 |
Trim32 |
tripartite motif-containing 32 |
234448 |
0.02 |
chr13_29015223_29015589 | 7.43 |
A330102I10Rik |
RIKEN cDNA A330102I10 gene |
887 |
0.68 |
chr13_78200366_78200817 | 7.34 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
813 |
0.37 |
chr19_36534720_36535517 | 7.33 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr13_78200105_78200283 | 7.28 |
A830082K12Rik |
RIKEN cDNA A830082K12 gene |
416 |
0.46 |
chr7_61940314_61940588 | 7.27 |
Mir344-2 |
microRNA 344-2 |
345 |
0.79 |
chr1_33947103_33947453 | 7.21 |
Gm28631 |
predicted gene 28631 |
16407 |
0.12 |
chr10_38554976_38555136 | 7.21 |
Gm22911 |
predicted gene, 22911 |
60425 |
0.15 |
chr15_13392917_13393530 | 7.04 |
Gm8238 |
predicted gene 8238 |
25633 |
0.22 |
chr9_37454600_37454751 | 7.03 |
Robo3 |
roundabout guidance receptor 3 |
21429 |
0.1 |
chr12_52010002_52010599 | 6.93 |
Dtd2 |
D-tyrosyl-tRNA deacylase 2 |
3799 |
0.19 |
chr5_103160778_103160955 | 6.77 |
Mapk10 |
mitogen-activated protein kinase 10 |
45063 |
0.16 |
chr18_43393020_43393658 | 6.75 |
Dpysl3 |
dihydropyrimidinase-like 3 |
38 |
0.98 |
chr14_124677137_124677288 | 6.74 |
Fgf14 |
fibroblast growth factor 14 |
85 |
0.98 |
chrX_96712988_96713192 | 6.73 |
Gpr165 |
G protein-coupled receptor 165 |
351 |
0.93 |
chr8_34890619_34890939 | 6.70 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
628 |
0.77 |
chr14_24826586_24826762 | 6.67 |
Gm47906 |
predicted gene, 47906 |
6961 |
0.27 |
chr12_46248746_46248904 | 6.62 |
Gm18112 |
predicted gene, 18112 |
25059 |
0.22 |
chr12_66471196_66471347 | 6.62 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
213 |
0.93 |
chr9_10269473_10269801 | 6.60 |
Gm24496 |
predicted gene, 24496 |
20950 |
0.22 |
chr14_64585752_64585966 | 6.52 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
1472 |
0.34 |
chr10_16053290_16053544 | 6.37 |
C330004P14Rik |
RIKEN cDNA C330004P14 gene |
261640 |
0.02 |
chr7_92985099_92985250 | 6.37 |
Gm31663 |
predicted gene, 31663 |
3122 |
0.24 |
chr1_51697455_51697651 | 6.29 |
Gm28055 |
predicted gene 28055 |
347 |
0.91 |
chr2_21010740_21011090 | 6.23 |
Gm13375 |
predicted gene 13375 |
41861 |
0.14 |
chr1_85598209_85599024 | 6.16 |
Sp110 |
Sp110 nuclear body protein |
133 |
0.84 |
chr10_33623576_33623727 | 6.15 |
Clvs2 |
clavesin 2 |
545 |
0.44 |
chr12_39956297_39956455 | 6.12 |
Gm18939 |
predicted gene, 18939 |
5744 |
0.21 |
chr1_56726194_56726492 | 6.08 |
Hsfy2 |
heat shock transcription factor, Y-linked 2 |
88908 |
0.09 |
chr13_78181984_78182157 | 6.07 |
Gm38604 |
predicted gene, 38604 |
1089 |
0.41 |
chr4_67590126_67590300 | 5.85 |
Gm44497 |
predicted gene, 44497 |
42940 |
0.19 |
chr5_131794362_131794585 | 5.83 |
4930563F08Rik |
RIKEN cDNA 4930563F08 gene |
85796 |
0.06 |
chr13_84062036_84062199 | 5.82 |
Gm17750 |
predicted gene, 17750 |
2655 |
0.31 |
chr7_72774892_72775043 | 5.69 |
Gm7693 |
predicted gene 7693 |
61346 |
0.12 |
chr6_125231367_125232148 | 5.68 |
Tapbpl |
TAP binding protein-like |
103 |
0.8 |
chr3_5347364_5347521 | 5.66 |
Zfhx4 |
zinc finger homeodomain 4 |
105770 |
0.07 |
chr10_38554173_38554374 | 5.61 |
Gm22911 |
predicted gene, 22911 |
61208 |
0.14 |
chr1_176946368_176946519 | 5.61 |
Gm15423 |
predicted gene 15423 |
13732 |
0.13 |
chr2_126932364_126933545 | 5.56 |
Sppl2a |
signal peptide peptidase like 2A |
281 |
0.9 |
chr2_127521161_127522051 | 5.54 |
Kcnip3 |
Kv channel interacting protein 3, calsenilin |
236 |
0.88 |
chr2_66178208_66178542 | 5.54 |
Gm13618 |
predicted gene 13618 |
9461 |
0.18 |
chr10_64090435_64090586 | 5.50 |
Lrrtm3 |
leucine rich repeat transmembrane neuronal 3 |
233 |
0.96 |
chr15_60631031_60631209 | 5.49 |
Gm48946 |
predicted gene, 48946 |
39223 |
0.17 |
chr14_124676975_124677126 | 5.47 |
Fgf14 |
fibroblast growth factor 14 |
77 |
0.98 |
chr4_102534118_102534322 | 5.40 |
Pde4b |
phosphodiesterase 4B, cAMP specific |
35875 |
0.22 |
chr5_29735522_29736024 | 5.40 |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
85 |
0.61 |
chr1_118911182_118911412 | 5.40 |
Mir6346 |
microRNA 6346 |
42923 |
0.16 |
chr11_24162075_24162437 | 5.36 |
4930538E20Rik |
RIKEN cDNA 4930538E20 gene |
10525 |
0.15 |
chr3_89233602_89234072 | 5.35 |
Muc1 |
mucin 1, transmembrane |
2366 |
0.09 |
chr1_57083188_57083527 | 5.34 |
9130024F11Rik |
RIKEN cDNA 9130024F11 gene |
42964 |
0.14 |
chr3_94477580_94477909 | 5.29 |
Celf3 |
CUGBP, Elav-like family member 3 |
551 |
0.54 |
chr13_56774410_56774604 | 5.28 |
Gm45623 |
predicted gene 45623 |
20680 |
0.21 |
chr1_104049444_104049595 | 5.25 |
Gm18447 |
predicted gene, 18447 |
262202 |
0.02 |
chr13_6646990_6647946 | 5.13 |
Pfkp |
phosphofructokinase, platelet |
1257 |
0.46 |
chr1_6733683_6734408 | 5.13 |
St18 |
suppression of tumorigenicity 18 |
825 |
0.73 |
chr5_133983531_133983706 | 5.13 |
Gm2404 |
predicted gene 2404 |
63616 |
0.11 |
chr1_171412046_171412381 | 5.12 |
Usf1 |
upstream transcription factor 1 |
532 |
0.57 |
chr4_110050502_110051534 | 5.07 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chrX_143851388_143851539 | 5.07 |
Capn6 |
calpain 6 |
24049 |
0.19 |
chr4_32326858_32327250 | 5.04 |
Bach2it1 |
BTB and CNC homology 2, intronic transcript 1 |
75293 |
0.1 |
chr12_3364588_3366025 | 5.00 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr18_8054510_8054913 | 5.00 |
Gm4833 |
predicted gene 4833 |
3508 |
0.33 |
chr14_14345884_14346978 | 4.99 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr1_66320533_66320701 | 4.97 |
Map2 |
microtubule-associated protein 2 |
1102 |
0.5 |
chr3_74921305_74921457 | 4.96 |
Gm37464 |
predicted gene, 37464 |
103234 |
0.08 |
chr6_108146271_108146552 | 4.96 |
Sumf1 |
sulfatase modifying factor 1 |
1716 |
0.39 |
chr3_8508798_8509116 | 4.96 |
Stmn2 |
stathmin-like 2 |
403 |
0.87 |
chr10_21881982_21882361 | 4.92 |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
13 |
0.97 |
chr13_119754800_119754951 | 4.87 |
Nim1k |
NIM1 serine/threonine protein kinase |
1007 |
0.33 |
chr7_79497714_79498195 | 4.86 |
Mir9-3hg |
Mir9-3 host gene |
2072 |
0.16 |
chr9_82710155_82710306 | 4.85 |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
119310 |
0.06 |
chr18_63924766_63925000 | 4.85 |
Gm24384 |
predicted gene, 24384 |
15727 |
0.21 |
chr8_23596316_23596734 | 4.82 |
Zmat4 |
zinc finger, matrin type 4 |
39494 |
0.19 |
chr1_128590793_128591469 | 4.82 |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
1159 |
0.52 |
chr11_25697617_25697787 | 4.80 |
Gm23514 |
predicted gene, 23514 |
12562 |
0.27 |
chr3_50300411_50300562 | 4.79 |
Gm2345 |
predicted gene 2345 |
45631 |
0.16 |
chr5_20197195_20197346 | 4.72 |
Magi2 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
5299 |
0.26 |
chr16_77400634_77400819 | 4.69 |
Gm21816 |
predicted gene, 21816 |
121 |
0.94 |
chr14_16439834_16440126 | 4.68 |
Top2b |
topoisomerase (DNA) II beta |
14552 |
0.23 |
chr10_100865897_100866065 | 4.68 |
Gm35722 |
predicted gene, 35722 |
124346 |
0.05 |
chr4_55294488_55294771 | 4.66 |
Gm25419 |
predicted gene, 25419 |
5216 |
0.16 |
chr5_20751911_20752076 | 4.65 |
Phtf2 |
putative homeodomain transcription factor 2 |
22120 |
0.16 |
chr4_22488420_22489023 | 4.63 |
Pou3f2 |
POU domain, class 3, transcription factor 2 |
355 |
0.83 |
chr17_88275094_88275304 | 4.63 |
1700116H05Rik |
RIKEN cDNA 1700116H05 gene |
30179 |
0.17 |
chr13_44043664_44043853 | 4.63 |
Gm33489 |
predicted gene, 33489 |
25236 |
0.17 |
chr1_42695117_42695493 | 4.63 |
Pou3f3 |
POU domain, class 3, transcription factor 3 |
380 |
0.35 |
chr14_14350947_14351733 | 4.62 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr10_17478823_17479016 | 4.62 |
Gm47768 |
predicted gene, 47768 |
35811 |
0.16 |
chr14_19986647_19987041 | 4.61 |
Gng2 |
guanine nucleotide binding protein (G protein), gamma 2 |
9217 |
0.21 |
chr4_32358732_32359062 | 4.61 |
Bach2 |
BTB and CNC homology, basic leucine zipper transcription factor 2 |
58538 |
0.13 |
chr14_75219258_75219666 | 4.61 |
Gm15629 |
predicted gene 15629 |
20191 |
0.12 |
chr5_27873604_27873982 | 4.60 |
Gm5551 |
predicted gene 5551 |
13344 |
0.15 |
chr13_78183985_78184266 | 4.60 |
Gm38604 |
predicted gene, 38604 |
957 |
0.45 |
chr4_87702951_87703126 | 4.59 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
103256 |
0.07 |
chr3_82406341_82406796 | 4.57 |
Map9 |
microtubule-associated protein 9 |
26495 |
0.24 |
chr12_99087280_99087574 | 4.54 |
Gm47116 |
predicted gene, 47116 |
23969 |
0.17 |
chr6_71012525_71012690 | 4.52 |
Gm23485 |
predicted gene, 23485 |
27126 |
0.15 |
chr4_22835459_22835658 | 4.52 |
Gm24078 |
predicted gene, 24078 |
88427 |
0.09 |
chr7_96277595_96277820 | 4.49 |
Mir6394 |
microRNA 6394 |
27960 |
0.16 |
chr18_42644502_42645243 | 4.49 |
C030004G16Rik |
RIKEN cDNA C030004G16 gene |
22413 |
0.16 |
chr16_70725367_70725548 | 4.48 |
Gm49665 |
predicted gene, 49665 |
22265 |
0.23 |
chr18_74950938_74951089 | 4.48 |
Lipg |
lipase, endothelial |
10249 |
0.1 |
chr6_112809545_112809826 | 4.48 |
Srgap3 |
SLIT-ROBO Rho GTPase activating protein 3 |
19774 |
0.21 |
chr10_46827266_46827417 | 4.47 |
Gm25650 |
predicted gene, 25650 |
11166 |
0.24 |
chr12_7029541_7029692 | 4.47 |
Gm46311 |
predicted gene, 46311 |
62656 |
0.16 |
chr9_42123592_42123975 | 4.46 |
Sorl1 |
sortilin-related receptor, LDLR class A repeats-containing |
514 |
0.8 |
chr18_35512848_35512999 | 4.43 |
Sil1 |
endoplasmic reticulum chaperone SIL1 homolog (S. cerevisiae) |
13143 |
0.08 |
chr3_17326409_17326732 | 4.42 |
Gm30340 |
predicted gene, 30340 |
7855 |
0.24 |
chr14_105851365_105851748 | 4.40 |
Gm48970 |
predicted gene, 48970 |
10945 |
0.21 |
chr14_8003068_8003458 | 4.37 |
Abhd6 |
abhydrolase domain containing 6 |
297 |
0.89 |
chr2_6594259_6594464 | 4.37 |
Celf2 |
CUGBP, Elav-like family member 2 |
1561 |
0.51 |
chr4_24019307_24019462 | 4.36 |
Gm28448 |
predicted gene 28448 |
85430 |
0.11 |
chr9_61102260_61102431 | 4.35 |
4933433G08Rik |
RIKEN cDNA 4933433G08 gene |
3040 |
0.19 |
chr3_124320498_124320693 | 4.34 |
Tram1l1 |
translocation associated membrane protein 1-like 1 |
260 |
0.9 |
chr6_22794011_22794374 | 4.33 |
Gm25942 |
predicted gene, 25942 |
4374 |
0.18 |
chr9_61278608_61278759 | 4.33 |
B930092H01Rik |
RIKEN cDNA B930092H01 gene |
15126 |
0.21 |
chr17_73713775_73713940 | 4.32 |
Galnt14 |
polypeptide N-acetylgalactosaminyltransferase 14 |
3404 |
0.28 |
chr14_48903732_48903883 | 4.31 |
Gm534 |
predicted gene 534 |
21938 |
0.13 |
chr9_96838099_96838474 | 4.28 |
Pxylp1 |
2-phosphoxylose phosphatase 1 |
16638 |
0.13 |
chr10_59104867_59105018 | 4.27 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
24908 |
0.19 |
chr18_23036938_23037296 | 4.26 |
Nol4 |
nucleolar protein 4 |
1539 |
0.55 |
chr12_39301586_39301824 | 4.23 |
Gm18591 |
predicted gene, 18591 |
92813 |
0.08 |
chr15_4374523_4374771 | 4.21 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
844 |
0.74 |
chr16_78101721_78102248 | 4.21 |
Gm5675 |
predicted gene 5675 |
15116 |
0.21 |
chr3_17789514_17789745 | 4.20 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
292 |
0.9 |
chr18_83523941_83524284 | 4.20 |
Gm50416 |
predicted gene, 50416 |
1192 |
0.46 |
chr14_47808207_47808496 | 4.17 |
Gm41148 |
predicted gene, 41148 |
3002 |
0.19 |
chr14_15785133_15785550 | 4.14 |
Gm31804 |
predicted gene, 31804 |
11652 |
0.26 |
chr14_118001575_118002132 | 4.13 |
Dct |
dopachrome tautomerase |
25682 |
0.18 |
chr2_97543385_97543550 | 4.11 |
Lrrc4c |
leucine rich repeat containing 4C |
75378 |
0.11 |
chr3_17788774_17789074 | 4.10 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
997 |
0.54 |
chr3_73053654_73054054 | 4.10 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
3089 |
0.24 |
chr1_85600326_85601326 | 4.07 |
Sp140 |
Sp140 nuclear body protein |
123 |
0.9 |
chr2_83813748_83813899 | 4.07 |
Fam171b |
family with sequence similarity 171, member B |
1187 |
0.44 |
chr7_64697335_64697486 | 4.07 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
31992 |
0.2 |
chr15_18820434_18820612 | 4.04 |
Cdh10 |
cadherin 10 |
194 |
0.94 |
chr10_99451329_99451513 | 4.01 |
Gad1-ps |
glutamate decarboxylase 1, pseudogene |
7377 |
0.15 |
chr17_9776345_9776976 | 4.00 |
4930452A19Rik |
RIKEN cDNA 4930452A19 gene |
793 |
0.69 |
chr13_68707508_68707920 | 3.98 |
Gm26929 |
predicted gene, 26929 |
102366 |
0.06 |
chr1_78190714_78190948 | 3.97 |
Pax3 |
paired box 3 |
6007 |
0.24 |
chr19_10869991_10870359 | 3.97 |
Tmem132a |
transmembrane protein 132A |
235 |
0.86 |
chr2_105719588_105719763 | 3.97 |
Gm13954 |
predicted gene 13954 |
10676 |
0.18 |
chr5_30711641_30712178 | 3.96 |
Dpysl5 |
dihydropyrimidinase-like 5 |
8 |
0.97 |
chr16_37938714_37939016 | 3.95 |
Gpr156 |
G protein-coupled receptor 156 |
22369 |
0.15 |
chr6_28795409_28795701 | 3.91 |
Gm37940 |
predicted gene, 37940 |
908 |
0.6 |
chr6_114283326_114283477 | 3.90 |
Slc6a1 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 |
611 |
0.81 |
chr12_44337938_44338345 | 3.88 |
Nrcam |
neuronal cell adhesion molecule |
8891 |
0.18 |
chr19_40433871_40434028 | 3.86 |
Sorbs1 |
sorbin and SH3 domain containing 1 |
17438 |
0.21 |
chr13_29826518_29826793 | 3.86 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
28776 |
0.23 |
chr2_51082664_51083121 | 3.86 |
Rnd3 |
Rho family GTPase 3 |
66202 |
0.12 |
chr10_20944709_20944873 | 3.85 |
Ahi1 |
Abelson helper integration site 1 |
7756 |
0.23 |
chr7_129778771_129778945 | 3.85 |
Gm44778 |
predicted gene 44778 |
54188 |
0.15 |
chr1_82292424_82293208 | 3.83 |
Irs1 |
insulin receptor substrate 1 |
1400 |
0.42 |
chr4_130865591_130865782 | 3.83 |
Gm22660 |
predicted gene, 22660 |
7806 |
0.15 |
chr5_22486687_22486871 | 3.81 |
Gm43110 |
predicted gene 43110 |
13787 |
0.13 |
chr3_119154908_119155345 | 3.81 |
Gm43410 |
predicted gene 43410 |
286882 |
0.01 |
chr13_39523613_39524251 | 3.79 |
Gm47351 |
predicted gene, 47351 |
9171 |
0.2 |
chr8_4868874_4869054 | 3.79 |
Rpl21-ps14 |
ribosomal protein L21, pseudogene 14 |
7795 |
0.18 |
chr4_66923734_66923885 | 3.77 |
Tlr4 |
toll-like receptor 4 |
95607 |
0.09 |
chr11_16941428_16941706 | 3.77 |
Eldr |
Egfr long non-coding downstream RNA |
9475 |
0.16 |
chr17_78415277_78415578 | 3.77 |
Fez2 |
fasciculation and elongation protein zeta 2 (zygin II) |
2264 |
0.26 |
chr15_100983527_100983682 | 3.76 |
Scn8a |
sodium channel, voltage-gated, type VIII, alpha |
13482 |
0.18 |
chr9_91386867_91387031 | 3.76 |
Zic4 |
zinc finger protein of the cerebellum 4 |
4539 |
0.14 |
chr5_149495653_149495848 | 3.75 |
Gm2566 |
predicted gene 2566 |
7302 |
0.14 |
chr2_79351345_79351496 | 3.74 |
Gm22606 |
predicted gene, 22606 |
3055 |
0.24 |
chr1_185493582_185493919 | 3.72 |
5033404E19Rik |
RIKEN cDNA 5033404E19 gene |
3638 |
0.2 |
chr12_120014837_120015071 | 3.71 |
Gm27236 |
predicted gene 27236 |
14427 |
0.24 |
chr3_97854648_97854838 | 3.70 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
13454 |
0.18 |
chr5_27262464_27262678 | 3.70 |
Dpp6 |
dipeptidylpeptidase 6 |
596 |
0.8 |
chr7_79504399_79504670 | 3.70 |
Mir9-3 |
microRNA 9-3 |
730 |
0.45 |
chr12_72265742_72265893 | 3.69 |
Rtn1 |
reticulon 1 |
29093 |
0.19 |
chr6_81660570_81661025 | 3.69 |
Gm26264 |
predicted gene, 26264 |
22486 |
0.22 |
chr13_59145653_59145960 | 3.68 |
Gm34307 |
predicted gene, 34307 |
22 |
0.53 |
chr12_117344591_117345571 | 3.66 |
Gm5441 |
predicted gene 5441 |
8059 |
0.29 |
chr5_111943856_111944042 | 3.65 |
Gm42488 |
predicted gene 42488 |
286 |
0.94 |
chr6_113012483_113012899 | 3.63 |
Gm8083 |
predicted gene 8083 |
20569 |
0.09 |
chr1_175692535_175693373 | 3.63 |
Chml |
choroideremia-like |
53 |
0.67 |
chr1_132741093_132741380 | 3.63 |
Nfasc |
neurofascin |
521 |
0.79 |
chr13_26656976_26657325 | 3.61 |
Gm47883 |
predicted gene, 47883 |
23543 |
0.23 |
chr17_66479760_66480028 | 3.60 |
Rab12 |
RAB12, member RAS oncogene family |
20425 |
0.14 |
chr15_66239660_66240017 | 3.60 |
Kcnq3 |
potassium voltage-gated channel, subfamily Q, member 3 |
46213 |
0.14 |
chr18_60923667_60923881 | 3.60 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
1844 |
0.26 |
chr2_180837659_180837810 | 3.60 |
Gm14344 |
predicted gene 14344 |
1253 |
0.3 |
chr3_68071831_68071996 | 3.59 |
Schip1 |
schwannomin interacting protein 1 |
7111 |
0.31 |
chr16_42339557_42339849 | 3.58 |
Gap43 |
growth associated protein 43 |
948 |
0.66 |
chr14_64593254_64594174 | 3.58 |
Mir3078 |
microRNA 3078 |
2529 |
0.21 |
chr14_58071780_58071984 | 3.57 |
Fgf9 |
fibroblast growth factor 9 |
804 |
0.62 |
chr8_69149162_69149554 | 3.57 |
Lzts1 |
leucine zipper, putative tumor suppressor 1 |
8405 |
0.17 |
chr14_66319706_66319909 | 3.56 |
Gm41183 |
predicted gene, 41183 |
21422 |
0.13 |
chr18_33447562_33447713 | 3.55 |
Nrep |
neuronal regeneration related protein |
15798 |
0.2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 11.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.9 | 5.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.8 | 5.5 | GO:0060594 | mammary gland specification(GO:0060594) |
1.8 | 11.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
1.8 | 5.5 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
1.8 | 15.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.7 | 6.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.7 | 11.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.4 | 4.3 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.4 | 4.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.3 | 5.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
1.3 | 7.6 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.2 | 5.8 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
1.1 | 3.3 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
1.1 | 4.4 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.1 | 4.3 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
1.0 | 2.0 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.9 | 2.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.9 | 2.7 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 6.2 | GO:0097264 | self proteolysis(GO:0097264) |
0.9 | 2.6 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.9 | 2.6 | GO:0019086 | late viral transcription(GO:0019086) |
0.8 | 3.3 | GO:0060916 | mesenchymal cell proliferation involved in lung development(GO:0060916) |
0.8 | 6.5 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.8 | 2.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.8 | 0.8 | GO:0030035 | microspike assembly(GO:0030035) |
0.7 | 2.2 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.7 | 2.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.7 | 1.5 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.7 | 2.2 | GO:0031296 | B cell costimulation(GO:0031296) |
0.7 | 2.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.7 | 2.1 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.7 | 8.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.7 | 2.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.7 | 5.4 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.7 | 2.0 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 2.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.7 | 3.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.7 | 5.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.7 | 2.6 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.6 | 3.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.6 | 4.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.6 | 2.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 1.2 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.6 | 1.9 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.6 | 1.8 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.6 | 5.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.6 | 1.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.6 | 2.4 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.6 | 1.8 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.6 | 2.4 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.6 | 2.3 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.6 | 1.7 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.6 | 4.0 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 2.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.6 | 1.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 2.7 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.5 | 2.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.5 | 1.6 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.5 | 3.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.5 | 1.1 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.5 | 9.1 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 1.6 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.5 | 1.6 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.5 | 1.1 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.5 | 2.6 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.5 | 1.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.5 | 2.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 2.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.5 | 1.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.5 | 1.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 2.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 1.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.5 | 1.9 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.5 | 3.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.5 | 1.4 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.4 | 1.3 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 1.8 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.3 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
0.4 | 0.4 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.4 | 2.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.4 | 0.8 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.4 | 2.9 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.4 | 1.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 0.8 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.4 | 1.6 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 2.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 1.2 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 4.4 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.4 | 1.6 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.4 | 0.8 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.4 | 1.6 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 1.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.4 | 1.1 | GO:0032512 | regulation of protein phosphatase type 2B activity(GO:0032512) |
0.4 | 1.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.4 | 1.5 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 2.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.4 | 2.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.4 | 3.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 0.4 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 3.5 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 3.2 | GO:0007614 | short-term memory(GO:0007614) |
0.4 | 1.1 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.3 | 1.0 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.3 | 1.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.7 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 1.4 | GO:0001927 | exocyst assembly(GO:0001927) |
0.3 | 2.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.7 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.3 | 1.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 0.7 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 1.0 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.3 | 2.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.3 | 0.3 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.3 | 3.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.3 | GO:0051794 | regulation of catagen(GO:0051794) |
0.3 | 1.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.3 | 1.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.3 | 1.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.3 | 2.5 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
0.3 | 0.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.3 | 1.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.3 | 2.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 4.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 0.9 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 2.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.3 | 0.3 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
0.3 | 0.6 | GO:0071435 | potassium ion export(GO:0071435) |
0.3 | 1.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.3 | 0.6 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 0.3 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.3 | 0.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.3 | 0.9 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 1.2 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.3 | 2.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 1.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.3 | 0.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.3 | 0.6 | GO:0098597 | observational learning(GO:0098597) |
0.3 | 3.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 0.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 0.5 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.3 | 0.8 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.3 | 6.2 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.3 | 0.5 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.3 | 0.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 1.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.3 | 1.8 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.3 | 0.8 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 0.8 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.3 | 1.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.3 | 1.3 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.3 | 0.3 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.3 | 0.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.3 | 1.0 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 1.0 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 2.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.2 | 1.5 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.2 | 3.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.2 | 3.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.2 | 1.0 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.7 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.7 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.5 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 0.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.2 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.7 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.2 | 1.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.2 | 1.2 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.2 | 0.9 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.2 | 0.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.2 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
0.2 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.2 | 0.5 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.2 | 0.9 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
0.2 | 2.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.2 | 3.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 0.9 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.2 | 1.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.7 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 0.4 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.2 | 1.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.2 | 14.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 3.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.4 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.2 | 0.6 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 2.3 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 3.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 1.1 | GO:0071625 | vocalization behavior(GO:0071625) |
0.2 | 0.4 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
0.2 | 0.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 1.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.3 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 1.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 3.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.2 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 0.6 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 0.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.6 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.2 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 6.0 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.2 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 3.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.2 | 0.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.2 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.2 | 1.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 1.7 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.2 | 1.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.8 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.2 | 0.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.7 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 2.2 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
0.2 | 0.2 | GO:0061356 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.2 | 0.7 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.7 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.9 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.2 | 1.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.2 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 0.7 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.3 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 0.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 1.0 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 0.3 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 0.5 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.3 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.7 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.2 | 0.5 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.2 | 0.7 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 2.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 0.5 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.2 | 1.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.2 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.2 | 0.8 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.2 | 0.5 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 0.3 | GO:2000822 | regulation of fear response(GO:1903365) positive regulation of fear response(GO:1903367) regulation of behavioral fear response(GO:2000822) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.5 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.2 | 0.5 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.2 | 4.4 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.2 | 7.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.2 | 0.6 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 9.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 0.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.2 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.9 | GO:0071436 | sodium ion export(GO:0071436) |
0.2 | 0.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.7 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 0.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.1 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.9 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.1 | 1.0 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.1 | 0.4 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 1.4 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 1.1 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 1.7 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.5 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.1 | 0.1 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.1 | 0.5 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.1 | 0.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 1.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.9 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.6 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 1.0 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.4 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 0.5 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.1 | GO:1902661 | regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
0.1 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 2.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.1 | 0.2 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.1 | 1.5 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.1 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.1 | 1.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.1 | 0.4 | GO:0003149 | membranous septum morphogenesis(GO:0003149) |
0.1 | 0.2 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.1 | 0.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.1 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.9 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.3 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.1 | 0.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.2 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.2 | GO:0035696 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.1 | 0.5 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.1 | 0.1 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.1 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 1.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.8 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.4 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 1.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.9 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.1 | 0.1 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.5 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.7 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.1 | 0.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.1 | 0.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.1 | 0.3 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.1 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
0.1 | 0.7 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.1 | 0.1 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 0.2 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.1 | 0.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.1 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.1 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.1 | 0.3 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 1.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.1 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.4 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.1 | 0.3 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.2 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.1 | 0.2 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 1.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 1.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.2 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.1 | 0.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.4 | GO:0034370 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
0.1 | 2.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.1 | 0.3 | GO:0043584 | nose development(GO:0043584) |
0.1 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.3 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.1 | 0.1 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.2 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 1.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.5 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.1 | 0.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.1 | 0.7 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 0.2 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.1 | 0.2 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.1 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.1 | 0.1 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.1 | 0.7 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.4 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.8 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 1.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.1 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.1 | 0.2 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.1 | 2.3 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 0.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.4 | GO:0046473 | phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
0.1 | 0.3 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.1 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.3 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 3.0 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.1 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.1 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.1 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.8 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.1 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.1 | 0.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0061548 | ganglion development(GO:0061548) |
0.1 | 0.8 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.1 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.2 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 0.1 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.1 | 0.1 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.1 | 0.1 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.1 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.1 | 0.1 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.1 | 0.2 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.1 | 0.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.2 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 0.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.1 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.4 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.8 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.1 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.0 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.2 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.1 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.2 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.2 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.0 | 0.0 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.0 | 0.2 | GO:0006862 | nucleotide transport(GO:0006862) |
0.0 | 0.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.3 | GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:0042790) |
0.0 | 0.3 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 2.4 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.5 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.3 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:0042640 | anagen(GO:0042640) |
0.0 | 1.3 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.0 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.0 | 0.1 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.0 | 0.0 | GO:0009757 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.1 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.2 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.2 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.0 | 0.1 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.2 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.0 | 0.0 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.1 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.0 | 0.7 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.0 | 0.0 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.0 | 0.2 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.2 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 0.2 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.0 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.0 | 0.1 | GO:0060166 | olfactory pit development(GO:0060166) |
0.0 | 0.3 | GO:0008209 | androgen metabolic process(GO:0008209) |
0.0 | 0.0 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
0.0 | 0.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.0 | 0.0 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.1 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.0 | 0.4 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.1 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.0 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.0 | 0.2 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.2 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.2 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.0 | 0.1 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.0 | 0.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.0 | 0.0 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.0 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.2 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.0 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.0 | 0.3 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.0 | 0.1 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.4 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.1 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.0 | 0.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.0 | 0.1 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.0 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.1 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.0 | 0.2 | GO:0001964 | startle response(GO:0001964) |
0.0 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.0 | 0.1 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.2 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.6 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.0 | 1.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.0 | 0.0 | GO:0070672 | response to interleukin-15(GO:0070672) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.3 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.0 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.1 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.1 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 1.4 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0042891 | antibiotic transport(GO:0042891) |
0.0 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.1 | GO:0032276 | regulation of gonadotropin secretion(GO:0032276) |
0.0 | 0.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.0 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.0 | 0.0 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.0 | 0.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.0 | 0.0 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.0 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.2 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.0 | GO:0090427 | activation of meiosis(GO:0090427) |
0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) |
0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.2 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.0 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.0 | 0.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.1 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.0 | 0.0 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.0 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.0 | 0.1 | GO:0097341 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) regulation of endosome size(GO:0051036) |
0.0 | 0.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.0 | 0.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 0.2 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.0 | 0.0 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.0 | 0.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.0 | 0.0 | GO:0090148 | membrane fission(GO:0090148) |
0.0 | 0.0 | GO:0071042 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.0 | 0.0 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.0 | 0.1 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.0 | 0.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.1 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.0 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.0 | GO:0010912 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.0 | 0.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.0 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.0 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.0 | 0.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.0 | GO:0072093 | metanephric renal vesicle formation(GO:0072093) |
0.0 | 0.0 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 0.1 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.0 | 0.0 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.0 | 0.0 | GO:0032645 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
0.0 | 0.0 | GO:0051584 | positive regulation of neurotransmitter uptake(GO:0051582) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.0 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.0 | 0.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.0 | 0.0 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.0 | 0.0 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.0 | 0.0 | GO:2000391 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.0 | 0.0 | GO:1902074 | response to salt(GO:1902074) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.9 | 5.6 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.9 | 2.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.8 | 4.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.7 | 2.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 2.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 2.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 2.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.6 | 9.7 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 2.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.6 | 3.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.6 | 1.7 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.6 | 2.8 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 5.6 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 5.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.5 | 1.5 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.4 | 1.8 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.4 | 5.0 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 12.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 1.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.1 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 2.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.3 | 1.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.0 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.3 | 0.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.3 | 5.3 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 3.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.3 | 0.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 7.9 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 2.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.9 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 3.2 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.7 | GO:0043203 | axon hillock(GO:0043203) |
0.3 | 3.0 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 7.5 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 18.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 2.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 28.7 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 1.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 1.5 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 1.0 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.0 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
0.2 | 10.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 0.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 2.0 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 0.6 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 1.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 1.4 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.2 | 0.9 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 3.0 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.7 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.2 | 6.6 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.2 | 1.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 0.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.2 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 2.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 0.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.1 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.0 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.1 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.0 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.6 | GO:0097433 | dense body(GO:0097433) |
0.1 | 1.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.4 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 1.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 1.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.5 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.5 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 2.7 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 14.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 1.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.4 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 1.6 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.4 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 5.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.1 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 0.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.9 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.1 | 1.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.6 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.1 | 4.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 7.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.0 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.0 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 3.6 | GO:0060076 | excitatory synapse(GO:0060076) |
0.0 | 0.8 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 0.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.3 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.3 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.5 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
0.0 | 0.0 | GO:0031523 | Myb complex(GO:0031523) |
0.0 | 2.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 2.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.0 | 0.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.0 | 0.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0045293 | mRNA editing complex(GO:0045293) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 1.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.0 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 1.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.1 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.0 | 0.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.0 | GO:1990393 | 3M complex(GO:1990393) |
0.0 | 0.0 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.0 | 0.0 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.0 | 0.0 | GO:0032010 | phagolysosome(GO:0032010) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 12.6 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.9 | 14.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.9 | 5.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.7 | 6.8 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.2 | 3.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.2 | 5.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.2 | 3.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
1.1 | 3.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
1.0 | 5.8 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.9 | 2.6 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.8 | 3.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.7 | 2.9 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.7 | 2.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 4.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.7 | 18.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 3.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.6 | 1.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.6 | 14.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 2.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.6 | 1.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.6 | 2.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.6 | 3.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.5 | 1.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 4.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.0 | GO:0043199 | sulfate binding(GO:0043199) |
0.5 | 1.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.5 | 2.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 1.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.5 | 2.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 2.2 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.4 | 1.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.4 | 1.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.4 | 2.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 5.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 1.2 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.4 | 1.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 1.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 1.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.4 | 1.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.4 | 2.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.4 | 2.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.4 | 4.6 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 1.7 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.3 | 1.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.3 | 2.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 12.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.3 | 1.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.3 | 1.0 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.3 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 2.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.3 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 3.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.3 | 0.9 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 3.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 0.6 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.3 | 2.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 1.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 1.4 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 0.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.3 | 4.8 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 0.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 1.6 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 1.6 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 3.6 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.3 | 1.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.3 | 0.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 2.7 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 0.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.2 | 2.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.2 | GO:0035276 | ethanol binding(GO:0035276) |
0.2 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
0.2 | 0.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 3.3 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 2.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 1.1 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.2 | 0.6 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 1.0 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 0.2 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 1.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.2 | 1.9 | GO:0051378 | serotonin binding(GO:0051378) |
0.2 | 0.6 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 1.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.2 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 1.7 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 2.9 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.2 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.2 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 1.1 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 1.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.2 | 0.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 0.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 0.5 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 0.6 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 0.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 0.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 1.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 2.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 3.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 1.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 1.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 2.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 1.0 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 1.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.3 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.1 | 2.7 | GO:0052715 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.1 | 0.4 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 2.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0032357 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.1 | 0.4 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.1 | 0.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.6 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.1 | 0.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 2.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 1.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 3.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.7 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.1 | 2.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.4 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 1.2 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.1 | 0.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 2.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 3.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.1 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 2.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 2.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.3 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 0.3 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.1 | 0.2 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.3 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.1 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.1 | 0.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.5 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 1.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.8 | GO:0036218 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.1 | 0.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.5 | GO:0034805 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.4 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.3 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 4.9 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.6 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.2 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 1.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.1 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0018598 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.3 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.1 | 0.3 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.3 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 1.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 1.2 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.8 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 1.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 1.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 1.8 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.0 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 1.3 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.2 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.6 | GO:0019111 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 1.9 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 0.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.8 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 2.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.2 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.1 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.7 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.0 | 1.4 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.1 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.0 | 0.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 0.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.0 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.3 | GO:0015250 | water channel activity(GO:0015250) |
0.0 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.1 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.7 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 2.7 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.1 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.7 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.0 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 0.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.0 | 0.1 | GO:1901677 | phosphate transmembrane transporter activity(GO:1901677) |
0.0 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.0 | 0.1 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.0 | 0.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.0 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.0 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.0 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.1 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 12.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.2 | 0.9 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 4.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 3.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 2.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 4.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 2.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 3.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 4.3 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 0.1 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 2.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.7 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 10.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.4 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.3 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.7 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.0 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 12.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.6 | 2.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 5.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 7.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 2.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.3 | 3.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 4.8 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 3.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.3 | 6.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.3 | 5.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 0.9 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
0.3 | 2.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.3 | 2.1 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 0.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 5.0 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 1.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 4.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 0.6 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 5.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 2.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.2 | 5.7 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 1.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 7.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 2.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 2.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.1 | 1.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 0.3 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 1.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 2.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 2.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 1.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.1 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 2.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 2.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.1 | 1.2 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.8 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.1 | 1.1 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.5 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 1.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 1.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.1 | 2.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.5 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 1.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.0 | 0.0 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.1 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.1 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.0 | 1.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |